NEXTBio Capital Management’s ADARx Pharmaceuticals, Inc. Common Stock ADRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.99M Buy
+100,000
New +$2M 0.85% 23

Other funds holding ADRX

NEXTBio Capital Management's ADRX Position: Q3 2026 in Review

NEXTBio Capital Management opened a new position in ADARx Pharmaceuticals, Inc. Common Stock (ADRX) in Q3 2026: 100,000 shares worth $1.99M. The stake represents 0.85% of the portfolio and ranks #23 among its holdings.

26 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.

  • NEXTBio Capital Management held 100,000 shares of ADARx Pharmaceuticals, Inc. Common Stock worth $1.99M as of Q3 2026.
  • ADARx Pharmaceuticals, Inc. Common Stock was a new NEXTBio Capital Management position in Q3 2026.
  • ADARx Pharmaceuticals, Inc. Common Stock made up 0.85% of NEXTBio Capital Management's portfolio in Q3 2026, its #23 holding.
  • 26 funds tracked by Wall St. Rank held ADARx Pharmaceuticals, Inc. Common Stock as of Q3 2026.

Based on NEXTBio Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.